Logo of Rocketdna (ASX:RKT)Latest Rocketdna (ASX:RKT) News

Page 1
Page 1 of 3

Technology Wrap - Week 44 (26 Oct -> 30 Oct) 2026

Technology shares swung widely this week, with DXN and Spectur hit by heavy selling while ION Video surged on new testing programmes. Cash shortages remained a major concern, even as software companies reported stronger recurring sales and new enterprise deals.
Logan Eniac
31 Oct 2026

RocketDNA crosses a recurring revenue threshold as xBot deployments accelerate

RocketDNA’s unaudited Q3 FY26 revenue rose 31% year-on-year to A$2.46 million, while xBot recurring revenue exceeded half of group revenue for the first time. The shift comes alongside expanding deployments, a A$2.23 million placement and continued cash investment in the platform.
Sophie Babbage
29 Oct 2026

Technology Wrap - Week 41 (5 Oct -> 9 Oct) 2026

Online gaming and workforce software stocks led the week, while several companies fell despite better operating news.
Investors still want proof that new contracts, funding and product launches can produce lasting cash.
Logan Eniac
10 Oct 2026

RocketDNA raises $2.23m to accelerate xBot deployments and software development

RocketDNA has secured $2.23 million through a strategic placement priced at a 2.4% premium to its last traded price. The funding will support xBot hardware deployment, software engineering, cyber-security accreditation and working capital, while major shareholder Daniel Narayan lifts his stake to 19.5%.
Sophie Babbage
8 Oct 2026

Technology Wrap - Week 32 (3 Aug -> 7 Aug) 2026

Pentanet led the technology board with a 53.33% weekly rise, while Ava Risk Group and Acusensus also posted strong gains. Software subscriptions, AI tools and cloud services drove many company updates, but some early share-price gains faded.
Logan Eniac
8 Aug 2026

RocketDNA Extends $1M Drone Contract with BMA in Bowen Basin

RocketDNA Ltd has secured a $1 million contract extension from BHP Mitsubishi Alliance to continue its autonomous drone operations in the Bowen Basin until October 2026, reinforcing its position in mining tech.
Sophie Babbage
7 Aug 2026

Technology Wrap - Week 30 (20 July -> 24 July) 2026

Nanoveu led the week after live drone trials, while Gratifii slumped on deal changes and X2M dropped after a discounted capital raising. Across the tech board, buyers backed real revenue, cash receipts and contract wins, but punished dilution, legal noise and weak post-gap trading.
Logan Eniac
25 July 2026

RocketDNA Grows Revenue and Expands Enterprise Drone Deployments in Q2 FY26

RocketDNA reported a 52% year-on-year revenue increase and expanded its autonomous drone operations with four new enterprise customers in Q2 FY26. The company also advanced software integration with Deswik to embed drone data into mine-planning workflows.
Sophie Babbage
22 July 2026

Market Wrap - Week 27 (29 June -> 3 July) 2026

A tiny gold explorer, a battery materials stock and a biotech name led a week packed with dealmaking, drilling news and fresh funding. Resources did most of the heavy lifting, while several big gaps either held firm or gave back part of their early jump.
Logan Eniac
4 July 2026

Technology Wrap - Week 27 (29 June -> 3 July) 2026

Big swings hit ASX tech as tiny GCM surged, Objective slumped on a Defence contract loss, and DXN fell despite landing new work. Away from the biggest price moves, the week was packed with raisings, acquisitions and fresh AI, quantum and enterprise contract news.
Logan Eniac
4 July 2026

RocketDNA Scales Skylink OS Across All Enterprise Clients with 25,000 Missions Booked

RocketDNA has fully deployed its Skylink® Operating System to all enterprise customers, driving over 1,000 active users and securing a 12-month pipeline of 25,000 pre-scheduled drone missions.
Sophie Babbage
1 July 2026

Technology Wrap - Week 25 (15 June -> 19 June) 2026

Space batteries, telecom AI and a healthcare software leadership change drove the week’s biggest moves in small-cap tech. Capital raisings and debt deals also shaped trading, with several early jumps fading as investors weighed dilution and execution risk.
Logan Eniac
20 June 2026